A novel nomogram for predicting HBeAg clearance in HBeAg-positive chronic hepatitis B patients after nucleos (t)ide analogues treatment

被引：0
|
作者：
Gu, Yan [1 ]
Wang, Jian [2 ,3 ]
Zhang, Zhiyi [1 ]
Zhang, Shaoqiu [2 ]
Zhang, Yao [1 ]
Ding, Weimao [4 ]
Li, Jie [1 ,2 ,3 ]
Huang, Rui [1 ,2 ,3 ]
Wu, Chao [1 ,2 ,3 ]
机构：
[1] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp Clin Coll Tradit Chinese, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Drum Tower Hosp, Affiliated Hosp Nanjing Univ Med Sch, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China
[4] Huaian 4 Peoples Hosp, Dept Hepatol, Huaian, Jiangsu, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-212
引用
收藏
页码：S1128 / S1129
页数：2
相关论文
共 50 条
  • [1] A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
    Gu, Yan
    Zhang, Yao
    Zhang, Zhiyi
    Wang, Jian
    Zhang, Qing
    Zhang, Shaoqiu
    Liu, Yilin
    Liu, Jiacheng
    Xia, Juan
    Yan, Xiaomin
    Li, Jie
    Liu, Xingxiang
    Huang, Rui
    Wu, Chao
    [J]. ANNALS OF HEPATOLOGY, 2024, 29 (01)
  • [2] Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues
    Leung, Nancy
    [J]. LIVER INTERNATIONAL, 2011, 31 : 85 - 89
  • [3] TREATMENT OF HBEAG-POSITIVE CHRONIC DELTA HEPATITIS WITH NUCLEOS(T)IDE ANALOGS
    Yurdaydin, Cihan
    Bozkaya, Hakon
    Heidrich, Benjamin
    Cakalogu, Yilmaz
    Deterding, Katja
    Akarca, Ulus S.
    Tillmann, Hans L.
    Uzunalimoglu, Ozden
    Bozdayi, A. Mithat
    Manns, Michael P.
    Wedemeyer, Heiner
    [J]. HEPATOLOGY, 2008, 48 (04) : 722A - 722A
  • [4] LONG-TERM OUTCOMES AFTER NUCLEOS(T)IDE ANALOGUES DISCONTINUATION IN CHRONIC HEPATITIS B PATIENTS WHO ARE HBeAg-POSITIVE
    He, D.
    Tao, S.
    Guo, S.
    Wang, Y.
    Ding, M.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S443 - S443
  • [5] Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues
    Papatheodoridis, George V.
    [J]. LIVER INTERNATIONAL, 2011, 31 : 95 - 103
  • [6] HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues
    Wang, B.
    Carey, I.
    Bruce, M.
    Montague, S.
    Dusheiko, G.
    Agarwal, K.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 886 - 893
  • [7] Durability of virological response in HBeAg-positive chronic hepatitis B patients achieving HBeAg seroconversion during nucleos(t)ide analogue treatment
    Wilson, J. L.
    Thompson, A. J. V.
    Bell, S. J.
    Demediuk, B.
    Shaw, G.
    Watson, K. J. R.
    Desmond, P. V.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A306 - A306
  • [8] Factors associate with HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients after receiving oral neucleos(t)ide analogues
    Sriprayoon, Tassanee
    Pattaranutaporn, Pittayapoom
    Tanwandee, Tawesak
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 254 - 254
  • [9] OUTCOME OF 3-YEAR CONSOLIDATION THERAPY FOLLOWING HBEAG LOSS IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES
    Kim, J. K.
    Lee, K. S.
    Lee, J. I.
    Kang, A. Y.
    Chang, H. Y.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S592 - S592
  • [10] Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues
    Ding, Yang
    Dou, Xiaoguang
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 881 - 882
12345